148 related articles for article (PubMed ID: 3094526)
1. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
Sayhan O; Ozdemirli M; Nurten R; Bermek E
Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
Fendrick JL; Iglewski WJ; Moehring JM; Moehring TJ
Eur J Biochem; 1992 Apr; 205(1):25-31. PubMed ID: 1313365
[TBL] [Abstract][Full Text] [Related]
3. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
Bektaş M; Nurten R; Ergen K; Bermek E
Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
[TBL] [Abstract][Full Text] [Related]
4. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
Nygård O; Nilsson L
Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
[TBL] [Abstract][Full Text] [Related]
5. Cellular ADP-ribosylation of elongation factor 2.
Iglewski WJ
Mol Cell Biochem; 1994 Sep; 138(1-2):131-3. PubMed ID: 7898455
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
Burns G; Abraham AK; Vedeler A
FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
[TBL] [Abstract][Full Text] [Related]
7. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
Davydova EK; Ovchinnikov LP
FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
Galicka A; Sredzińska K; Gindzieński A
Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
[TBL] [Abstract][Full Text] [Related]
9. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
Nygård O; Nilsson L
J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
[TBL] [Abstract][Full Text] [Related]
10. ADP-ribosyltransferase from beef liver which ADP-ribosylates elongation factor-2.
Iglewski WJ; Lee H; Muller P
FEBS Lett; 1984 Jul; 173(1):113-8. PubMed ID: 6086394
[TBL] [Abstract][Full Text] [Related]
11. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
Riis B; Rattan SI; Clark BF
J Biochem Biophys Methods; 1989 Oct; 19(4):319-25. PubMed ID: 2693515
[TBL] [Abstract][Full Text] [Related]
12. Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.
Tsai SC; Adamik R; Moss J; Aktories K
Biochem Biophys Res Commun; 1988 May; 152(3):957-61. PubMed ID: 3132159
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
Sitikov AS; Davydova EK; Bezlepkina TA; Ovchinnikov LP; Spirin AS
FEBS Lett; 1984 Oct; 176(2):406-10. PubMed ID: 6208057
[TBL] [Abstract][Full Text] [Related]
14. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
[TBL] [Abstract][Full Text] [Related]
15. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
Giovane A; Balestrieri C; Quagliuolo L; Servillo L
FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
[TBL] [Abstract][Full Text] [Related]
16. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
Lee H; Iglewski WJ
Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
[TBL] [Abstract][Full Text] [Related]
17. ADP-ribosylatable content of elongation factor-2 changes during cell cycle of normal and cancerous human cells.
Riis B; Rattan SI; Cavallius J; Clark BF
Biochem Biophys Res Commun; 1989 Mar; 159(3):1141-6. PubMed ID: 2930555
[TBL] [Abstract][Full Text] [Related]
18. Purification and properties of an altered form of elongation factor 2 from mutant cells resistant to intoxication by diphtheria toxin.
Iglewski WJ; Lee H
Eur J Biochem; 1983 Aug; 134(2):237-40. PubMed ID: 6307688
[TBL] [Abstract][Full Text] [Related]
19. Purification of elongation factor 2 from human placenta and evidence of its fragmentation patterns in various eukaryotic sources.
Giovane A; Servillo L; Quagliuolo L; Balestrieri C
Biochem J; 1987 Jun; 244(2):337-44. PubMed ID: 3663126
[TBL] [Abstract][Full Text] [Related]
20. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
Wasson DB; Yamanaka H; Carson DA
Adv Exp Med Biol; 1989; 253B():213-8. PubMed ID: 2514587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
